Acute and Long-Term Results After Intra-arterial Thrombolysis of Occluded Lower Extremity Bypass Grafts Using Recombinant Tissue Plasminogen Activator for Acute Limb-Threatening Ischemia

2003 ◽  
Vol 10 (1) ◽  
pp. 3-6 ◽  
Author(s):  
Sandeep Khosla ◽  
Pankaj Jain ◽  
Ravi Manda ◽  
Mansour Razminia ◽  
Mayra Guerrero ◽  
...  
Keyword(s):  
Lower Extremity ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Recombinant Tissue Plasminogen Activator ◽  
Long Term Results ◽  
Bypass Grafts ◽  
Tissue Plasminogen ◽  
Arterial Thrombolysis

Thrombolysis in Acute Ischaemic Stroke Pathway

2008 ◽  
Vol 12 (2) ◽  
pp. 10-22
Author(s):  
Samuel Chew ◽  
Shahid A Kausar ◽  
Steve Sturman
Keyword(s):  
Ischaemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Acute Ischaemic Stroke ◽  
Clinical Excellence ◽  
Recombinant Tissue Plasminogen Activator ◽  
Acute Period ◽  
Management Of Complications ◽  
Tissue Plasminogen

Thrombolysis of appropriate and selected patients presenting with an acute ischaemic stroke within 3 h of onset with recombinant Tissue Plasminogen Activator (alteplase, r-TPA) can be implemented safely, reduce long-term disability, and is recommended by the National Institute of Health and Clinical Excellence and the Department of Health's National Stroke Strategy. We have developed an integrated and comprehensive pathway in order to achieve the above aims, which also provide guidelines for nursing in the peri-acute period and management of complications arising from the ischaemic stroke itself, from thrombolysis or from concomitant hyperglycaemia.

Sign in / Sign up

Export Citation Format

Share Document